Web Results

Alefacept

en.wikipedia.org/wiki/Alefacept

Alefacept is a genetically engineered immunosuppressive drug. It was sold under the brand name Amevive in Canada, the United States, Israel, Switzerland and ...

Amevive (alefacept) voluntarily discontinued in the U.S. | National ...

www.psoriasis.org/media/press-releases/amevive-alefacept-voluntarily-discontinued-us

Nov 16, 2011 ... Astellas Pharma U.S. Inc. (Astellas) has voluntarily discontinued the promotion, manufacturing, distribution and sales of Amevive (alefacept), ...

The safety and efficacy of alefacept in the treatment of chronic ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC2386357/

Alefacept is the first biological agent approved by the US Food and Drug Administration (FDA) for the treatment of moderate to severe chronic plaque psoriasis.

Alefacept - LiverTox - National Institutes of Health

livertox.nlm.nih.gov/Alefacept.htm

Alefacept is a recombinant fusion protein of lymphocyte function associated antigen-3 (LFA-3) and immunoglobulin G dimer that acts to inactive T cells, and is an ...

Amevive (alefacept) Uses, Dosage, Side Effects - Drugs.com

www.drugs.com/amevive.html

Amevive (alefacept) is a protein that reduces specific actions of the immune system that are involved in causing psoriasis. Amevive is used to treat plaque ...

Alefacept, Amevive, Biogen Inc, Package Insert - U.S. Food and ...

www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/ucm086009.pdf

intravenous injection contains 7.5 mg alefacept per 0.5 mL of reconstituted solution. ... administration, the mean volume of distribution of alefacept was 94 mL/kg, ...

Amevive (alefacept) - CenterWatch

www.centerwatch.com/drug-information/fda-approved-drugs/drug/820/amevive-alefacept

Amevive (alefacept): For moderate to severe chronic plaque psoriasis.. New approved drug details including side effects, uses and general information.

Alefacept (amevive). DermNet NZ

www.dermnetnz.org/treatments/alefacept.html

Feb 28, 2016 ... Alefacept. Alefacept belongs to the class of biological response modifiers called T-cell blockers. It is currently approved in the US for the ...

Discontinued Drug Bulletin: Alefacept Injection

www.ashp.org/menu/DrugShortages/DrugsNoLongerAvailable/bulletin.aspx?id=885

Jan 11, 2012 ... ASHP represents pharmacists who serve as patient care providers in acute and ambulatory settings. The organization's more than 43000 ...

JCI - Alefacept provides sustained clinical and immunological effects ...

www.jci.org/articles/view/81722

Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients. Mark R. Rigby,<sup>1</sup> Kristina M. Harris,<sup>2</sup> Ashley Pinckney,<sup>3</sup> ...

More Info

Amevive (Alefacept) Drug Information: Description, User Reviews ...

www.rxlist.com

AMEVIVE® (alefacept) is a CD2-directed LFA-3/Fc fusion protein that consists of the extracellular CD2-binding portion of the human leukocyte function antigen-3 ...

AMEVIVE (alefacept) DESCRIPTION CLINICAL PHARMACOLOGY

www.astellas.us

AMEVIVE® (alefacept) is an immunosuppressive dimeric fusion protein that consists ... AMEVIVE® for intramuscular injection contains 15 mg alefacept, 12.5 mg ...

alefacept, Amevive: Drug Facts, Side Effects and Dosing - MedicineNet

www.medicinenet.com

Jun 11, 2015 ... Alefacept (Amevive) medication for adults with moderate to severe placuqe psoriasis. Side effects, dosage, pregnancy safety information, and ...